Assignee
PERHA PHARMACEUTICALS
FR·1 granted patent·2 pending applications·0 citations·filing 2021–2022
Top patents by PatentIndex Score
3 records- 0146US2025340539A1Imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1, and/or clk4PERHA PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 0243US2025340538A1Imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4PERHA PHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 0341US12398129B2Imidazolone derivatives as inhibitors of protein kinases in particular DYRK1A, CLK1 and/or CLK4PERHA PHARMACEUTICALS·Filed 2021·Granted Aug 26, 2025·0 cites·18 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →